American International Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,858
| Closed | -$34K | – | 3299 |
|
|
2022
Q1 | $34K | Sell |
2,858
-201
| -7% | -$2.39K | ﹤0.01% | 2954 |
|
|
2021
Q4 | $100K | Sell |
3,059
-92
| -3% | -$3.01K | ﹤0.01% | 2716 |
|
|
2021
Q3 | $141K | Sell |
3,151
-75
| -2% | -$3.36K | ﹤0.01% | 2634 |
|
|
2021
Q2 | $176 | Buy |
3,226
+476
| +17% | +$26 | ﹤0.01% | 2592 |
|
|
2021
Q1 | $206 | Buy |
2,750
+337
| +14% | +$25 | ﹤0.01% | 2354 |
|
|
2020
Q4 | $262 | Sell |
2,413
-70
| -3% | -$8 | ﹤0.01% | 2136 |
|
|
2020
Q3 | $220K | Sell |
2,483
-56
| -2% | -$4.96K | ﹤0.01% | 2093 |
|
|
2020
Q2 | $271K | Buy |
2,539
+488
| +24% | +$52.1K | ﹤0.01% | 1955 |
|
|
2020
Q1 | $122K | Sell |
2,051
-119
| -5% | -$7.08K | ﹤0.01% | 2198 |
|
|
2019
Q4 | $150K | Sell |
2,170
-18
| -0.8% | -$1.24K | ﹤0.01% | 2386 |
|
|
2019
Q3 | $227K | Sell |
2,188
-15
| -0.7% | -$1.56K | ﹤0.01% | 2090 |
|
|
2019
Q2 | $204K | Buy |
2,203
+590
| +37% | +$54.6K | ﹤0.01% | 2218 |
|
|
2019
Q1 | $147K | Sell |
1,613
-53
| -3% | -$4.83K | ﹤0.01% | 2383 |
|
|
2018
Q4 | $93K | Sell |
1,666
-12
| -0.7% | -$670 | ﹤0.01% | 2636 |
|
|
2018
Q3 | $200K | Buy |
1,678
+83
| +5% | +$9.89K | ﹤0.01% | 2420 |
|
|
2018
Q2 | $163K | Buy |
1,595
+607
| +61% | +$62K | ﹤0.01% | 2488 |
|
|
2018
Q1 | $128K | Buy |
988
+145
| +17% | +$18.8K | ﹤0.01% | 2526 |
|
|
2017
Q4 | $82K | Buy |
843
+4
| +0.5% | +$389 | ﹤0.01% | 2809 |
|
|
2017
Q3 | $123K | Buy |
839
+63
| +8% | +$9.24K | ﹤0.01% | 2542 |
|
|
2017
Q2 | $125K | Buy |
776
+489
| +170% | +$78.8K | ﹤0.01% | 2589 |
|
|
2017
Q1 | $46K | Buy |
+287
| New | +$46K | ﹤0.01% | 2859 |
|